{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:14:44Z","timestamp":1778170484968,"version":"3.51.4"},"reference-count":20,"publisher":"Japan Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1507\/endocrj.ej22-0146","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T22:12:07Z","timestamp":1656022327000},"page":"1343-1349","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of a new enzyme-linked immunosorbent assay system for three islet cell autoantibodies in Japanese patients with acute-onset type 1 diabetes"],"prefix":"10.1507","volume":"69","author":[{"given":"Tomoyasu","family":"Fukui","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine, Tokyo 142-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Takehana","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine, Tokyo 142-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusaku","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine, Tokyo 142-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munenori","family":"Hiromura","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine, Tokyo 142-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michishige","family":"Terasaki","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine, Tokyo 142-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Kushima","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine, Tokyo 142-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiya","family":"Takada","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Showa University Northern Yokohama Hospital, Kanagawa 224-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Tomoyasu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Showa University Northern Yokohama Hospital, Kanagawa 224-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuko","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine, Tokyo 142-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine, Tokyo 142-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Ohara","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine, Tokyo 142-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Cosmic Corporation Co., Ltd, Tokyo 112-0002, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Ito","sequence":"additional","affiliation":[{"name":"Eiju General Hospital, Tokyo 110-8645, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Division of Immunology and Molecular Medicine, Okinaka Memorial Institute for Medical Research, Tokyo 105-8470, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho-ichi","family":"Yamagishi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine, Tokyo 142-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Eisenbarth GS (1986) Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 314: 1360\u20131368.","DOI":"10.1056\/NEJM198605223142106"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Coppieters KT, Dotta F, Amirian N, Campbell PD, Kay TW, et al. (2012) Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med 209: 51\u201360.","DOI":"10.1084\/jem.20111187"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Wenzlau JM, Hutton JC (2013) Novel diabetes autoantibodies and prediction of type 1 diabetes. Curr Diab Rep 13: 608\u2013615.","DOI":"10.1007\/s11892-013-0405-9"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Kawasaki E (2014) Type 1 diabetes and autoimmunity. Clin Pediatr Endocrinol 23: 99\u2013105.","DOI":"10.1297\/cpe.23.99"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5 Gabbay MA, Sato MN, Duarte AJ, Dib SA (2012) Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients. Clin Exp Immunol 168: 60\u201367.","DOI":"10.1111\/j.1365-2249.2011.04538.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Redondo MJ, Geyer S, Steck AK, Sharp S, Wentworth JM, et al. (2018) A type 1 diabetes genetic risk score predicts progression of islet autoimmunity and development of type 1 diabetes in individuals at risk. Diabetes Care 41: 1887\u20131894.","DOI":"10.2337\/dc18-0087"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Ziegler AG, Kick K, Bonifacio E, Haupt F, Hippich M, et al. (2020) Yield of a public health screening of children for islet autoantibodies in Bavaria, Germany. JAMA 323: 339\u2013351.","DOI":"10.1001\/jama.2019.21565"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Amoroso M, Achenbach P, Powell M, Coles R, Chlebowska M, et al. (2016) 3 screen islet cell autoantibody ELISA: a sensitive and specific ELISA for the combined measurement of autoantibodies to GAD65, to IA-2 and to ZnT8. Clin Chim Acta 462: 60\u201364.","DOI":"10.1016\/j.cca.2016.08.013"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Ziegler AG, Haupt F, Scholz M, Weininger K, Wittich S, et al. (2016) 3 screen ELISA for high-throughput detection of beta cell autoantibodies in capillary blood. Diabetes Technol Ther 18: 687\u2013693.","DOI":"10.1089\/dia.2016.0199"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Kawasaki E, Maruyama T, Imagawa A, Awata T, Ikegami H, et al. (2014) Diagnostic criteria for acute-onset type 1 diabetes mellitus (2012): Report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus. J Diabetes Investig 5: 115\u2013118.","DOI":"10.1111\/jdi.12119"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Brooking H, Ananieva-Jordanova R, Arnold C, Amoroso M, Powell M, et al. (2003) A sensitive non-isotopic assay for GAD65 autoantibodies. Clin Chim Acta 331: 55\u201359.","DOI":"10.1016\/S0009-8981(03)00088-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Chen S, Willis J, Maclean C, Ananieva-Jordanova R, Amoroso MA, et al. (2005) Sensitive non-isotopic assays for autoantibodies to IA-2 and to a combination of both IA-2 and GAD65. Clin Chim Acta 357: 74\u201383.","DOI":"10.1016\/j.cccn.2005.02.006"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Dunseath G, Ananieva-Jordanova R, Coles R, Powell M, Amoroso M, et al. (2015) Bridging-type enzyme-linked immunoassay for zinc transporter 8 autoantibody measurements in adult patients with diabetes mellitus. Clin Chim Acta 447: 90\u201395.","DOI":"10.1016\/j.cca.2015.05.010"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, et al. (2012) International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Investig 3: 39\u201340.","DOI":"10.1111\/j.2040-1124.2012.00207.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Saydah SH, Shrestha SS, Zhang P, Zhou X, Imperatore G (2019) Medical costs among youth younger than 20 years of age with and without diabetic ketoacidosis at the time of diabetes diagnosis. Diabetes Care 42: 2256\u20132261.","DOI":"10.2337\/dc19-1041"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Jonsdottir B, Larsson C, Carlsson A, Forsander G, Ivarsson SA, et al. (2017) Thyroid and islet autoantibodies predict autoimmune thyroid disease at type 1 diabetes diagnosis. J Clin Endocrinol Metab 102: 1277\u20131285.","DOI":"10.1210\/jc.2016-2335"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Kordonouri O, Charpentier N, Hartmann R (2011) GADA positivity at onset of type 1 diabetes is a risk factor for the development of autoimmune thyroiditis. Pediatr Diabetes 12: 31\u201333.","DOI":"10.1111\/j.1399-5448.2010.00666.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Murao S, Kondo S, Ohashi J, Fujii Y, Shimizu I, et al. (2008) Anti-thyroid peroxidase antibody, IA2 antibody, and fasting C-peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA)\u2014a 5-year follow-up of the Ehime study. Diabetes Res Clin Pract 80: 114\u2013121.","DOI":"10.1016\/j.diabres.2008.01.024"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Kamijo K (2007) TSH-receptor antibodies determined by the first, second and third generation assays and thyroid-stimulating antibody in pregnant patients with Graves\u2019 disease. Endocr J 54: 619\u2013624.","DOI":"10.1507\/endocrj.K06-196"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 T\u00f6rn C, Vaziri-Sani F, Ramelius A, Elding Larsson H, Ivarsson SA, et al. (2022) Evaluation of the RSR 3 screen ICA<sup>TM<\/sup> and 2 screen ICA<sup>TM<\/sup> as screening assays for type 1 diabetes in Sweden. Acta Diabetol 59: 773\u2013781.","DOI":"10.1007\/s00592-022-01856-5"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/69\/11\/69_EJ22-0146\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T03:16:36Z","timestamp":1670037396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/69\/11\/69_EJ22-0146\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej22-0146","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"EJ22-0146"}}